We are live on ! Find out more
NWBOW

Northwest Biotherapeutics, Inc.
NWBOW

Delisted

NWBOW was delisted on the 16th of December, 2016.

Back to rankings

2 hedge funds and large institutions have $439K invested in Northwest Biotherapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more capital invested

Capital invested by funds: $256K → $439K (+$183K)

0% more funds holding

Funds holding: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Allianz Asset Management
Allianz Asset Management
Germany
+$234K

Top Sellers

Rank Fund Capital Flow
1
AIG
American International Group
New York
-$2.46K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
1
Allianz Asset Management
Germany
$432K +$234K +81,620 +100%
AIG
2
American International Group
New York
$7K -$2.46K -860 -25%

NWBOW Hedge Fund Activity: Q4 2014 in Review

2 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Northwest Biotherapeutics, Inc. (NWBOW) for Q4 2014, worth a combined $439K — up 72% from $256K a quarter earlier.

Fund positioning in NWBOW was balanced in Q4 2014: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Allianz Asset Management, adding an estimated $234K. The largest seller was American International Group, cutting an estimated $2.46K.

  • 2 institutional investors held Northwest Biotherapeutics, Inc. (NWBOW) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $439K of Northwest Biotherapeutics, Inc. stock for Q4 2014, up 72% quarter-over-quarter.
  • 0 funds opened new Northwest Biotherapeutics, Inc. positions in Q4 2014 and 0 closed out.
  • The largest Northwest Biotherapeutics, Inc. buyer in Q4 2014 was Allianz Asset Management, an estimated $234K added.
  • The largest Northwest Biotherapeutics, Inc. seller in Q4 2014 was American International Group, an estimated $2.46K sold.

Based on aggregated 13F filings for Q4 2014.